EF Hutton
Finance · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
590 Madison Ave Fl 39, New York, New Yor...Website
www.efhutton.comRevenue
$45.4 MillionIndustry
About EF Hutton
EF Hutton Org Chart
Is EF Hutton your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on EF Hutton recently announced quarterly report
Click to see if EF Hutton had a recent Job posting/layoffs
Funding: Get notified immidiatlly once EF Hutton has new funding data
Check if EF Hutton has recently received funding, and reach out quickly before it becomes old news!
EF Hutton, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if EF Hutton is spiking on competitors!
Product Launch: Get notified when EF Hutton launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at EF Hutton
Recommended Actions
Find VP level buyers at EF Hutton
Find more new buyers
Company Profile Activity
Activity Insights
EF Hutton is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
EF Hutton is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about EF Hutton.
EF Hutton Tech Stack
A closer look at the technologies used by EF Hutton
Most Recent Scoops
EF Hutton News & Media
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack
NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it acted as exclusive financial advisor in connection with a $5.5 million financing for Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK).E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack
NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it acted as exclusive financial advisor in connection with a $5.5 million financing for Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK).Glucotrack, Inc. (NASDAQ: GCTK) secures $5.5M debt and equity financing - Stock Titan
Raises about $5.5M via $3.5M secured convertible notes and a $2.0M PIPE issuing pre-funded and common warrants tied to Glucotrack common stock.Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
RUTHERFORD, N.J. and SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), together with its operating business Lōkahi Therapeutics™ ("Lōkahi"), a clinical-stage biopharmaceutical company advancing innovative non-opioid biologic therapies and applying its proprietary ai²™ methodology to identify and develop high-value healthcare opportunities, today announced the completion of a bridge financing designed to support the Company's strategic g
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EF Hutton
EF Hutton is a rapidly growing full-service investment bank dedicated to providing strategic advice and customized financial solutions to middle market and emerging growth companies around the world.... Read More